A study of altered gene expression in frontal cortex from schizophrenic patients using differential screening

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Schizophrenia is a complex psychiatric disorder with an unclear molecular etiology.
• Previous research suggests potential alterations in brain gene expression in schizophrenia.

Purpose of the Study:

• To investigate molecular differences in the frontal cortex of individuals with schizophrenia compared to healthy controls.
• To identify specific genes or transcripts with altered abundance in schizophrenic brains.

Main Methods:

• Employed a sequential differential hybridization protocol to isolate differentially expressed mRNAs.
• Identified isolated cDNA sequences using database homology searches (EMBL, Genbank).
• Quantified specific mRNA levels (cytochrome oxidase) and mitochondrial DNA (mt-DNA) in patient and control samples.

Main Results:

• Isolated five cDNAs with abnormal abundance in schizophrenic frontal cortex.
• All five cDNAs corresponded to mitochondrial transcripts, including 12s rRNA, 16s rRNA, and cytochrome oxidase subunit II.
• Confirmed increased levels of cytochrome oxidase mRNA in schizophrenic patients, with no significant difference in mt-DNA levels.

Conclusions:

• The study identified specific mitochondrial gene expression abnormalities in the schizophrenic frontal cortex.
• These findings point towards a potential role of mitochondrial dysfunction in the pathophysiology of schizophrenia.
• The results highlight mitochondrial transcripts as potential biomarkers or targets for understanding schizophrenia.